NASDAQ NMS - GLOBAL MARKET · IRMD
-0.09% · -$0.0800 · Vol Not reported
Pre-market · updated 04:15:05 ET
IRadimed Corp

IRadimed Corp

Health Care
$85.39
Card
Relationship Map

Follow $IRMD

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IRMD by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
IRMD
IRadimed Corp
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

57/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IRMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IRMD catalysts
About IRadimed Corp
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2014
Employees
166
Country
US

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$85.47
Last session
Day high
$85.47
Last session
Day low
$85.47
Last session
Previous close
$85.47
52W high
$105.15
-18.79% from high
52W low
$71.68
41% of range
Market cap
$1.1B
P/E
49.07×
EPS
$1.74
Beta
0.09
Shares out
12.8M
Avg volume
130K
VWAP
$85.47
Last session
Price history computed in-house
1W
+0.11%
1M
+1.17%
3M
-12.15%
1Y
+11.08%
YTD
-12.22%
SMA 50 $86.84 · below
SMA 200 $93.51 · below
52W position 41%

IRMD overview

Veridion Score
57
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IRMD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IRMD Form 4 filings
Public disclosures

Congress activity in IRMD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

IRMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IRMD in this window.
Lobbying spend

IRMD lobbying filings, year to date.

Registered lobbying filings matched to IRadimed Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IRMD in this window.
Loading news for IRMD
Analyst ratings
Sovereign unlock shows live analyst consensus for IRMD.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.